Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.5 USD 16.28% Market Closed
Updated: Jun 2, 2024

Iterum Therapeutics PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iterum Therapeutics PLC
Net Income Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Iterum Therapeutics PLC
NASDAQ:ITRM
Net Income
-$35.6m
CAGR 3-Years
36%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Net Income
-$7.7m
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Net Income
$414.8m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
18%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Net Income
-$156.8m
CAGR 3-Years
-205%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
G
GH Research PLC
NASDAQ:GHRS
Net Income
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Net Income
€7.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-20%

See Also

What is Iterum Therapeutics PLC's Net Income?
Net Income
-35.6m USD

Based on the financial report for Mar 31, 2024, Iterum Therapeutics PLC's Net Income amounts to -35.6m USD.

What is Iterum Therapeutics PLC's Net Income growth rate?
Net Income CAGR 5Y
16%

Over the last year, the Net Income growth was 30%. The average annual Net Income growth rates for Iterum Therapeutics PLC have been 36% over the past three years , 16% over the past five years .